Smoking is the leading cause of preventable death in the United States and is implicated in an estimated 30% of all cancer deaths in this country. Recent studies indicate that smokers have average life expectancies that are 11-12 years shorter than those who have never smoked. Importantly, depending on the age that one quits, ex-smokers live up to a decade longer than those who do not quit. Although the prevalence of smoking has declined over the past several decades, approximately 34 million (15% of) adults continue to smoke in the United States. Nearly 70% of smokers report that they want to quit smoking, and 52% of all smokers try to quit each year.
Many studies have indicated that the combination of behavioral support with pharmacotherapy provides optimal smoking cessation outcomes. However, only 25% of U.S. adult cigarette smokers reported using nicotine patches or oral nicotine replacement therapy (NRT) during their most recent quit attempt, and only 15% sought help from a doctor or other health professional.
Recently, research has focused on evaluating combination pharmacotherapies in an effort to refine current evidence-based treatment approaches. Nicotine replacement therapy comes in various forms including a skin patch, lozenges, and gum. The patch provides a steady nicotine dose whereas the lozenges and gum can provide acute relief during cravings and high-risk situations. The lozenges offer individuals the flexibility to deliver nicotine when they need it most, in contrast with the continuous and passive delivery of nicotine offered via the patch. While NRT monotherapy has been shown to result in greater smoking cessation success rates than no cessation medication, combination NRT (e.g., patch+oral NRT) significantly outperforms NRT monotherapy. Unfortunately, most smokers who use oral NRT do not use it as directed and discontinue use prematurely, increasing the likelihood of smoking lapse. It is difficult to accurately monitor patient compliance with treatment protocols using conventional patient compliance surveys
Intelligent medication reminders that only prompt oral NRT use when a dose is missed could increase adherence and reduce the incidence of smoking lapse. Recent studies have shown that targeted alerts increase both acceptability and effectiveness, and increase medication adherence. There is, therefore, a need for an improved system and process for improving patient compliance with treatment protocols involving the periodic ingestion of oral medications, including, but not limited to, the oral ingestion of NRT lozenges. The present disclosure is directed to addressing these and other deficiencies in the prior art.
Tracking patient compliance with treatment protocols is an important aspect of delivering high quality healthcare. In one aspect, the present disclosure is directed, in non-limiting embodiments, to a system and method for improving compliance and monitoring of a treatment protocol that includes the periodic ingestion of oral medications. The system includes a mobile computing device and a pill tracking dispenser. The mobile computing device includes an application program configured to record the periodic consumption of oral medication by the patient. The pill tracking dispenser can be connected to the mobile computing device through a wireless network. The pill tracking dispenser is configured to report to the mobile computing device the number of times the oral medication is consumed by the patient.
In another aspect, the present disclosure is directed to a pill tracking dispenser that includes a pill chamber configured to contain a plurality of pills, a pill release mechanism, an electronics chamber that includes an onboard processing unit, and a gate sensor. The pill release mechanism includes a gate that permits a pill to be released from the pill chamber when the gate is opened. The onboard processing unit is configured to establish a data connection with an oral medication compliance system that includes a mobile computing device that is in turn configured for connection to a computer system. The gate position sensor is configured to detect the gate opening and provide the onboard processing unit with a signal that the gate was opened to permit the release of a pill.
In yet another aspect, the present disclosure is directed to a pill tracking dispenser configured for use within a system for tracking patient compliance with a treatment protocol that includes the periodic consumption of oral medication. In these embodiments, the pill tracking dispenser includes a pill chamber configured to contain a plurality of pills and a pill release mechanism that includes a gate that permits a pill to be released from the pill chamber when the gate is opened. The pill tracking dispenser also includes a trigger connected to the gate, where the trigger can be manipulated by the patient to move the gate into an open position. The pill tracking dispenser 102 further includes an onboard processing unit that is configured to establish a data connection with a mobile computing device that is in turn configured for connection to a computer system used by a clinician in monitoring the patient's compliance with the treatment protocol.
Beginning with
In exemplary embodiments, the mobile computing device 104 is a smartphone or tablet that is configured to be connected to the pill tracking dispenser 102 with a paired wireless data connection, such as through a Bluetooth or Wi-Fi connection protocol. In some embodiments, the pill tracking dispenser 102 and mobile computing device 104 are configured to exchange data each time a connection is available between the two devices. In other embodiments, the pill tracking dispenser 102 and mobile computing device 104 exchange data on a delayed, periodic basis (e.g., not more than twice per 24 hour period).
The mobile computing device 104 includes an application program 112 that retrieves pill release event data from the pill tracking dispenser 102, stores the pill release data on the mobile computing device 104, and transfers the pill release data to the mobile computing device 104 and/or computer system 106 for analysis. The application program 112 can be configured to provide the patient with information about the number of pills 108 released from the pill tracking dispenser 102 and whether the pills 108 were released in compliance with an established treatment protocol stored within the application program 112. The application program 112 can also be configured to alert the patient that it is time to dispense and ingest a pill 108 in accordance with a treatment protocol stored within the application program 112. The treatment protocol within the application program 112 can be remotely updated by a clinician using the networked connection between the computer system 106 and the mobile computing device 104. With this information, the application program 112 can be configured to provide treatment protocol compliance information to the patient through a visual interface on the mobile computing device 104.
In addition to exchanging compliance information between the pill tracking dispenser 102 and the computer system 106, the oral medication compliance system 100 can be configured to assist the patient with ordering refills for the oral medication 108. In some embodiments, the application program 112 is configured to advise the patient that it is time to refill the oral medication 108 available through the pill tracking dispenser 102. In other embodiments, the application program 112 is configured to automatically communicate with a clinician at the computer system 106 to request refill instructions and permissions. In yet other embodiments, the application program 112 and computer system 106 cooperate to automatically request and fulfill a refill of the oral medication 108 through an online pharmacy or other supplier.
Turning to
The oral medication 108 is contained within the pill chamber 116 and released from the pill tracking dispenser 102 by actuating the pill release mechanism 118. In the embodiment depicted in
In embodiments that include the safety latch 136, the safety latch 136 must be retracted to withdraw the locking tab 138 from the gate 128 before the gate 128 can be opened with the trigger 130. A button 140 on the safety latch 136 can be used to manipulate the safety latch 136 between locked and unlocked positions. Thus, to release a pill 108, the patient must first unlock the safety latch 136 by pulling the button away from the gate 128 until the locking tab 138 is fully withdrawn from the gate 128. While holding the safety latch 136 in the unlocked position, the patient can then open the gate 128 by pressing down on the trigger 130 against the force of the gate spring 134. Once the trigger 130 and button 140 are released, the gate 128 closes and the safety latch 136 reengages in the locked position. In this way, two separate manipulations must be carried out to release a pill 108 from the pill tracking dispenser 102.
The onboard processing unit 124 includes a small microprocessor, digital memory, programming, an internal clock, and wireless network functionality (transmitter and receiver hardware). It will be appreciated that the onboard processing unit 124 may be a consolidated chip or a circuit board that includes a series of connected, but separate components. The onboard processing unit 124 can include an independent battery power source in addition to the primary battery 120. In some embodiments, the onboard processing unit 124 is configured to retrieve information from the mobile computing device 104 and to store that information within the pill tracking dispenser 102. For example, the onboard processing unit 124 can be configured to synchronize the internal clock within the onboard processing unit 124 with the date and time information on the mobile computing device 104.
The onboard processing unit 124 is operably connected to the gate position sensor 122. Each time the gate 128 is opened, the gate trips the gate position sensor 122, which is connected to the onboard processing unit 124. The gate position sensor 122 can be a mechanical switch that is closed (or opened) by interference with the moving gate 128. Each time the gate position sensor 122 is tripped, the onboard processing unit 124 records the gate opening event and correlates the event with the time the event took place. The record of each pill release event is stored within the onboard processing unit 124 and then automatically or manually transferred (uploaded) to the mobile computing device 104 when the pill tracking dispenser 102 is connected to the mobile computing device 104.
In some embodiments, the pill tracking dispenser 102 further includes a pill release sensor 142 that detects the actual movement of a pill 108 through the pill port 132. In some embodiments, the pill release sensor 142 is a small, low-power light curtain device that is activated when the gate position sensor 122 is triggered. Once activated, the pill release sensor 142 monitors the number of pills 108 that are discharged through the pill port 132 by detecting a sequence of breaks or interruptions in the light curtain. The output from the pill release sensor 142 is also provided to the onboard processing unit 124 so that the pill tracking dispenser 102 can track each gate opening event and the number of pills 108 dispensed while the gate 128 is in the open position. This prevents errors in compliance data that arise from multiple pills 108 being dispensed through a single gate opening event.
Turning to
Turning to
Thus, in the exemplary and non-limiting embodiments disclosed herein, an oral medication compliance system 100 includes a “smart” pill tracking dispenser 102 that is configured to track the release of pills 108 and provide that information to a patient, clinician, or study administrator through a networked connection that leverages the patient's mobile phone or other mobile computing device 104. The pill tracking dispenser 102 and oral medication compliance system 100 provide an effective tool for improving patient compliance with treatment protocols while also providing researchers or clinicians with valuable information about the correlation between patient outcomes and adherence to a treatment protocol.
It is to be understood that the terms “including”, “comprising”, “consisting” and grammatical variants thereof do not preclude the addition of one or more components, features, steps, or integers or groups thereof and that the terms are to be construed as specifying components, features, steps or integers. If the specification or claims refer to “an additional” element, that does not preclude there being more than one of the additional element. It is to be understood that where the claims or specification refer to “a” or “an” element, such reference is not be construed that there is only one of that element. It is to be understood that where the specification states that a component, feature, structure, or characteristic “may”, “might”, “can” or “could” be included, that particular component, feature, structure, or characteristic is not required to be included.
Where applicable, although state diagrams, flow diagrams or both may be used to describe embodiments, the present disclosure is not limited to those diagrams or to the corresponding descriptions. For example, flow need not move through each illustrated box or state, or in exactly the same order as illustrated and described. Methods of the present disclosure may be implemented by performing or completing manually, automatically, or a combination thereof, selected steps or tasks. The term “method” may refer to manners, means, techniques and procedures for accomplishing a given task including, but not limited to, those manners, means, techniques and procedures either known to, or readily developed from known manners, means, techniques and procedures by practitioners of the art to which the invention belongs.
For purposes of the instant disclosure, the term “at least” followed by a number is used herein to denote the start of a range beginning with that number (which may be a range having an upper limit or no upper limit, depending on the variable being defined). For example, “at least 1” means 1 or more than 1. The term “at most” followed by a number is used herein to denote the end of a range ending with that number (which may be a range having 1 or 0 as its lower limit, or a range having no lower limit, depending upon the variable being defined). For example, “at most 4” means 4 or less than 4, and “at most 40%” means 40% or less than 40%. Terms of approximation (e.g., “about”, “substantially”, “approximately”, etc.) should be interpreted according to their ordinary and customary meanings as used in the associated art unless indicated otherwise. Absent a specific definition and absent ordinary and customary usage in the associated art, such terms should be interpreted to be at least ±20%, or at least ±10%, or at least ±5% of the base value.
When, in this document, a range is given as “(a first number) to (a second number)” or “(a first number)−(a second number)”, this means a range whose lower limit is the first number and whose upper limit is the second number. For example, 25 to 100 should be interpreted to mean a range whose lower limit is 25 and whose upper limit is 100. Additionally, it should be noted that where a range is given, every possible subrange or interval within that range is also specifically intended unless the context indicates to the contrary. For example, if the specification indicates a range of 25 to 100 such range is also intended to include subranges such as 26-100, 27-100, etc., 25-99, 25-98, etc., as well as any other possible combination of lower and upper values within the stated range, e.g., 33-47, 60-97, 41-45, 28-96, etc. Note that integer range values have been used in this paragraph for purposes of illustration only and decimal and fractional values (e.g., 46.7-91.3) should also be understood to be intended as possible subrange endpoints unless specifically excluded. The range 0.5 mm to 10 mm is to be understood to include all integers within the range and decimal fractions within the range (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, and 0.6, 0.7, 0.8, 0.9, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, and 0.51, 0.52, 0.53, 0.54, 0.55, 0.56, 0.57, 0.58, 0.59, and so on).
It should be noted that where reference is made herein to a method comprising two or more defined steps, the defined steps can be carried out in any order or simultaneously (except where context excludes that possibility), and the method can also include one or more other steps which are carried out before any of the defined steps, between two of the defined steps, or after all of the defined steps (except where context excludes that possibility). Still further, additional aspects of the various embodiments of the instant disclosure may be found in one or more appendices attached hereto and/or filed herewith, the disclosures of which are incorporated herein by reference as if fully set out at this point.
Thus, the embodiments of the present disclosure are well adapted to carry out the objects and attain the ends and advantages mentioned above as well as those inherent therein. While the inventive device and system have been described and illustrated herein by reference to particular non-limiting embodiments in relation to the drawings attached thereto, various changes and further modifications, apart from those shown or suggested herein, may be made therein by those of ordinary skill in the art, without departing from the spirit of the inventive concepts.
This application claims the benefit of U.S. Provisional Patent Application Ser. No. 62/982,023 filed Feb. 26, 2020 entitled, “Medicine Dispenser with Patient Compliance Monitoring System,” the disclosure of which is herein incorporated by reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2021/019721 | 2/25/2021 | WO |
Number | Date | Country | |
---|---|---|---|
62982023 | Feb 2020 | US |